-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
[ Chemical Machinery Equipment Network Market Analysis ] If pharmaceutical companies want to develop and grow, they need to carry out informatization and digital upgrades to improve the level of pharmaceuticals, so as to ensure the quality and safety of drugs.
Based on this, the industry generally believes that the digital transformation of pharmaceutical companies will become an inevitable development trend.
Chemical machinery and equipment network market analysis chemical machinery and equipmentBased on this, the industry generally believes that the digital transformation of pharmaceutical companies will become an inevitable development trend.
It is understood that the obvious benefit of digital transformation for pharmaceutical companies is that it can help companies improve production efficiency and reduce costs.
In fact, traditional large pharmaceutical companies including GSK, Roche, Novartis, and AstraZeneca have all accelerated their digital transformation in recent years.
In China, although the digital transformation of domestic pharmaceutical companies is still in the preliminary stage compared with large multinational pharmaceutical companies, since 2020, affected by the special period, more and more domestic pharmaceutical companies have realized the limitations of the traditional model and began to pay attention And transform towards digitalization.
In fact, traditional large pharmaceutical companies including GSK, Roche, Novartis, and AstraZeneca have all accelerated their digital transformation in recent years.
In China, although the digital transformation of domestic pharmaceutical companies is still in the preliminary stage compared with large multinational pharmaceutical companies, since 2020, affected by the special period, more and more domestic pharmaceutical companies have realized the limitations of the traditional model and began to pay attention And transform towards digitalization.
Statistics show that since 2020, major pharmaceutical companies have significantly increased their investment in digital construction.
In 2019, digitization-related costs accounted for more than 10% of total product input costs, accounting for 23% of pharmaceutical companies, and in March 2020, the proportion has reached 40%.
From the above comprehensive point of view, pharmaceutical companies have become more and more aware of the significance of digital transformation in the increasingly fierce market competition.
The industry predicts that in the future, with the continuous advancement of policies such as the normalization of centralized drug procurement, as well as the rising costs of pharmaceutical companies and the increasingly fierce market competition, the digital transformation of pharmaceutical companies will become the general trend.
In 2019, digitization-related costs accounted for more than 10% of total product input costs, accounting for 23% of pharmaceutical companies, and in March 2020, the proportion has reached 40%.
From the above comprehensive point of view, pharmaceutical companies have become more and more aware of the significance of digital transformation in the increasingly fierce market competition.
The industry predicts that in the future, with the continuous advancement of policies such as the normalization of centralized drug procurement, as well as the rising costs of pharmaceutical companies and the increasingly fierce market competition, the digital transformation of pharmaceutical companies will become the general trend.
It is worth noting that in the process of pharmaceutical companies' digital transformation of production, the industry pointed out that pharmaceutical equipment companies may have a lot to do.
This conclusion is mainly due to the fact that after pharmaceutical companies realize digital production through pharmaceutical equipment, they can grasp the production status and control quality in real time, real-time reports and outgoing analysis, and greatly improve management efficiency.
Pharmaceutical equipmentThis conclusion is mainly due to the fact that after pharmaceutical companies realize digital production through pharmaceutical equipment, they can grasp the production status and control quality in real time, real-time reports and outgoing analysis, and greatly improve management efficiency.
The author has learned that, in fact, in recent years, a large number of pharmaceutical equipment companies have begun to step up their layout in terms of digitalization.
It is reported that a common problem in most pharmaceutical companies is that it is difficult to strictly guarantee the pharmaceutical level.
In response to this problem, existing pharmaceutical equipment companies have developed end-to-end digital solutions for pharmaceutical companies, aiming to make up for the shortcomings of pharmaceutical companies in the management of pharmaceutical workshops and meet the current development needs of domestic pharmaceutical companies.
According to its staff, “On the production side, this solution provides pharmaceutical companies with a solution for pharmaceutical companies to solve electronic batch records (EBR), production traceability, production execution, quality control, etc.
as the core pharmaceutical manufacturing execution system, and help pharmaceutical companies in the management and cooperation.
Improve management and accumulate big data in various aspects such as regulation, process precipitation, and quality improvement to help pharmaceutical companies achieve safety assurance and sustainable development capabilities.
"
It is reported that a common problem in most pharmaceutical companies is that it is difficult to strictly guarantee the pharmaceutical level.
In response to this problem, existing pharmaceutical equipment companies have developed end-to-end digital solutions for pharmaceutical companies, aiming to make up for the shortcomings of pharmaceutical companies in the management of pharmaceutical workshops and meet the current development needs of domestic pharmaceutical companies.
According to its staff, “On the production side, this solution provides pharmaceutical companies with a solution for pharmaceutical companies to solve electronic batch records (EBR), production traceability, production execution, quality control, etc.
as the core pharmaceutical manufacturing execution system, and help pharmaceutical companies in the management and cooperation.
Improve management and accumulate big data in various aspects such as regulation, process precipitation, and quality improvement to help pharmaceutical companies achieve safety assurance and sustainable development capabilities.
"
There are also pharmaceutical equipment companies that are using digital chromatography systems to shorten the manufacturing cycle of pharmaceutical equipment hardware, create, store, and call mature formulation processes, ensure the stability and reproducibility of pharmaceutical processes, and make the design of pharmaceutical equipment compatible with Manufacturing is more standardized and modular.
In addition, pharmaceutical equipment such as Chutian and Dongfulong have also been accelerating their upgrading and transformation.
Among them, Chutian Technology has already begun to use automation and information technology to successfully develop some intelligent pharmaceutical production robots and their production lines, transforming into an EPC service provider that builds an overall solution for the pharmaceutical industry 4.
0 smart factory.
And Tofflon and other industry enterprises are also vigorously developing towards the goal of building an Industry 4.
0 smart pharmaceutical factory.
Among them, Chutian Technology has already begun to use automation and information technology to successfully develop some intelligent pharmaceutical production robots and their production lines, transforming into an EPC service provider that builds an overall solution for the pharmaceutical industry 4.
0 smart factory.
And Tofflon and other industry enterprises are also vigorously developing towards the goal of building an Industry 4.
0 smart pharmaceutical factory.
In general, as more and more domestic pharmaceutical companies want to achieve digital production, the digital transformation and upgrading of pharmaceutical equipment companies will also become an important strategic choice and will usher in a huge room for development.
However, it is worth noting that in specific practice, the pharmaceutical equipment industry still has many issues that need to be considered, such as low automation, extensive production operations, intelligent pharmaceutical equipment, low digitalization, and how to reduce multiple costs and how to solve services.
Continuity, enhanced collaboration and integration, etc.
However, it is worth noting that in specific practice, the pharmaceutical equipment industry still has many issues that need to be considered, such as low automation, extensive production operations, intelligent pharmaceutical equipment, low digitalization, and how to reduce multiple costs and how to solve services.
Continuity, enhanced collaboration and integration, etc.
Therefore, in the digital age, pharmaceutical equipment companies also need to adjust their development models in a timely manner in accordance with the development of the times and market changes, and take a longer-term view.
Original title: In the digital age, the development prospects of the pharmaceutical machinery industry are bright
